Your web browser is out of date.
Your web browser is out of date.
Diabetes on the Net is intended for healthcare professionals
This year, the All-Ireland conference brings you the latest thinking and practical advice on diabetes in the primary care setting, and will be doing so in a virtual format. Covering a broad range of topics, the speakers will highlight what new initiatives and changes mean for you in your everyday practice. The mix of lectures from leading healthcare professionals and interactive practical workshops will enable you – whatever your role in the primary care diabetes team – to come away having consolidated and built on your knowledge. You will also be able to work through the online CPD/CME templates throughout the day that you can take away to add to your personal development portfolio, all aimed at helping you put what you learn into practice.
We hope you will join us, virtually, for what is sure to be another invaluable event for your professional development.
Irish Representatives of the PCDS
Joanne Lowe, Community Diabetes Nurse Specialist, Co Wicklow
Lisa Devine, GP, Co. Wicklow
Ask the experts your burning questions through the LIVE Q&A at the end of each session
Log on anytime during the day from the comfort of your own home to view the sessions
Don’t worry if you miss something, all of the content will be available on-demand
Claim 5 CPD/CME points points for the full-day virtual conference
09.00 - 09.10
09.10 - 09.40
An evidence-informed yet person-centred approach to the management of cardiovascular risk in type 2 diabetes
This is a promotional symposium slot sponsored by Lilly.
Please note this session is not eligible for accreditation.
Relevant prescribing information and adverse event reporting can be found on the platform
PP-LD-IE-0054 October 2021
11.25 - 12.05
Session organised and supported by Abbott Laboratories Ltd.
13.15 - 13.45
General Practitioner, Associate Clinical Director for Mental Health, and Dementia and Learning disabilities at Somerset CCG
Registered Advanced Midwife Practitioner, National Maternity Hospital, Dublin
Consultant Clinical Psychologist, Belfast Health and Social Care Trust
GP, Co. Wicklow
GPwSI in Diabetes and Medical Education, North Berwick
Consultant Endocrinologist and Honorary Senior Lecturer
Consultant Physician and Visiting Professor, Belfast
Community Diabetes Nurse Specialist, Co. Wicklow
Consultant Physician in Endocrinology and Diabetes,St.Columcille’s Hospital, Loughlinstown, Co Dublin, Ireland
Consultant Endocrinology and Diabetes
Registered Advanced Midwife Practitioner RAMP Diabetes, UL Hospitals Group, University Maternity Hospital
Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.
To learn more, visit www.lilly.ie
Napp Pharmaceuticals Limited
Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We strive to offer new medicines and initiatives that support the NHS in delivering effective, high-quality, sustainable healthcare for the benefit of patients
Abbott’s diabetes care division
At Abbott, we believe people with diabetes should have the freedom to enjoy a full, active life. That’s why we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor their glucose and providing healthcare teams with more data to drive better informed treatment decisions.
Boehringer Ingelheim and Lilly Diabetes Alliance
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: diabetes, haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 43,200 people in 80 countries and markets its products in more than 170 countries. Every day, millions of people all over the world rely on our products, which are manufactured in nine countries.
Novo Nordisk has a unique ownership structure, with two-thirds of Novo Nordisk’s shares controlled by the Novo Nordisk Foundation. The objective of the Foundation is to provide a stable basis for the commercial and research activities of Novo Nordisk and support scientific, humanitarian and social purposes.
As the acknowledged leader in diabetes care, we work to prevent, treat and ultimately cure this increasingly onerous disease. Over the past 90 years, our researchers have pioneered many breakthroughs in its management, and today, our determination to help these people is stronger than ever.
Novo Nordisk also holds leading positions in the management of bleeding disorders, growth hormone treatment and hormone replacement therapy. We are currently researching into novel delivery systems and autoimmune and chronic inflammatory diseases, using technologies such as translational immunology and monoclonal antibodies.